Back
Ares Capital Vs. Cassava Sciences Industry Stock Comparison
Sell
39
ARCC
Ares Capital
Last Price:
21.98
Seasonality Move:
0.91%
Buy
63
SAVA
Cassava Sciences
Last Price:
27.15
Seasonality Move:
47.33%
Sell
39
Ares Capital (ARCC)
is a Sell
Is Ares Capital a Buy, Sell or Hold?
- The current Ares Capital [ARCC] share price is $21.78. The Score for ARCC is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ARCC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Cassava Sciences (SAVA)
is a Buy
Is Cassava Sciences a Buy, Sell or Hold?
- The current Cassava Sciences [SAVA] share price is $32.18. The Score for SAVA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
- SAVA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ARCC Stock Price Chart
What is Ares Capital's stock price today?
-
The Ares Capital share price today is $21.78
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARCC is experiencing slight selling pressure.
SAVA Stock Price Chart
What is Cassava Sciences's stock price today?
-
The Cassava Sciences share price today is $32.18
The current trend is moderately bearish and SAVA is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARCC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.15 | Buy |
| Relative Strength Index (14 RSI): | 61.86 | Buy |
| Chaikin Money Flow: | -877171 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.25 - 21.75) | Buy |
| Bollinger Bands (100): | (20.58 - 21.4) | Buy |
SAVA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 64.8 | Buy |
| Chaikin Money Flow: | 2523870 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.39 - 28.53) | Buy |
| Bollinger Bands (100): | (17.94 - 31.2) | Buy |
ARCC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 21.66 | Buy |
| 20-day SMA: | 21.46 | Buy |
| 50-day SMA: | 21.17 | Buy |
| 200-day SMA: | 20.82 | Buy |
| 8-day EMA: | 21.67 | Buy |
| 20-day EMA: | 21.52 | Buy |
| 50-day EMA: | 21.28 | Buy |
| 200-day EMA: | 20.78 | Buy |
SAVA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.35 | Buy |
| 20-day SMA: | 26.62 | Buy |
| 50-day SMA: | 27.56 | Buy |
| 200-day SMA: | 22.93 | Buy |
| 8-day EMA: | 27.96 | Buy |
| 20-day EMA: | 27.22 | Buy |
| 50-day EMA: | 26.84 | Buy |
| 200-day EMA: | 24.22 | Buy |
Ares Capital Earnings Growth & ARCC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.14 per share.
Cassava Sciences Earnings Growth & SAVA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.98 per share, and an increase next year of $0.59 per share.
Ares Capital Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cassava Sciences Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||